Cargando…
Inhibition of Antiestrogen-Promoted Pro-Survival Autophagy and Tamoxifen Resistance in Breast Cancer through Vitamin D Receptor
We determined how vitamin D receptor (VDR) is linked to disease outcome in estrogen receptor-positive (ER+) breast cancer patients treated with tamoxifen (TAM). Breast cancer patients (n = 581) in four different datasets were divided into those expressing higher (above median) and lower levels of VD...
Autores principales: | Li, Ye, Cook, Katherine L, Yu, Wei, Jin, Lu, Bouker, Kerrie B, Clarke, Robert, Hilakivi-Clarke, Leena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159129/ https://www.ncbi.nlm.nih.gov/pubmed/34069442 http://dx.doi.org/10.3390/nu13051715 |
Ejemplares similares
-
Molecular mechanisms of tamoxifen-associated endometrial cancer (Review)
por: HU, RONG, et al.
Publicado: (2015) -
Genistein: does it prevent or promote breast cancer?
por: Bouker, K B, et al.
Publicado: (2000) -
Co-Inhibition of BCL-W and BCL2 Restores Antiestrogen Sensitivity through BECN1 and Promotes an Autophagy-Associated Necrosis
por: Crawford, Anatasha C., et al.
Publicado: (2010) -
Effects of Jaeumkanghwa-tang on tamoxifen responsiveness in preclinical ER+ breast cancer model
por: De Oliveira Andrade, Fabia, et al.
Publicado: (2019) -
FLTX2: A Novel Tamoxifen Derivative Endowed with Antiestrogenic, Fluorescent, and Photosensitizer Properties
por: Díaz, Mario, et al.
Publicado: (2021)